Search Result - Primary Antibodies

  • anti-CD134 / OX40 antibody [OX-86] (FITC)
  • Cat. No: ARG65838  (Rat mAb)
  • Reactivity: Ms
  • Application: FACS
  • Specificity: This antibody (clone OX-86) labels the OX-40 antigen found on both mouse CD4 and CD8 single positive activated T cells. This is in contrast to rat OX-86 mAb does not block binding of the OX-40L.
  • Conjugation: FITC
  • anti-CD134 / OX40 antibody [OX-86] (PE)
  • Cat. No: ARG65839  (Rat mAb)
  • Reactivity: Ms
  • Application: FACS
  • Specificity: This antibody (clone OX-86) labels the OX-40 antigen found on both mouse CD4 and CD8 single positive activated T cells. This is in contrast to rat OX-86 mAb does not block binding of the OX-40L.
  • Conjugation: PE
  • anti-CD262 / TRAIL R2 antibody [DR5-01-1] (APC)
  • Cat. No: ARG42324  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The mouse monoclonal antibody DR5-01-1 recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2 is one of two TNF superfamily members that contain death domain for TRAIL (APO2L).
  • Conjugation: APC
  • anti-CD263 / TRAIL R3 antibody [TRAIL-R3-02] (APC)
  • Cat. No: ARG42325  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The antibody TRAIL-R3-02 reacts with TRAIL-R3, a 35 kDa GPI-anchored extracellular membrane protein expressed mainly on neutrophils.
  • Conjugation: APC
  • anti-CD261 / TRAIL R1 antibody [DR-4-02] (FITC)
  • Cat. No: ARG53804  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone DR-4-02 recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 amino acids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumour-derived cell lines.
  • Conjugation: FITC
  • anti-CD261 / TRAIL R1 antibody [DR-4-02] (PE)
  • Cat. No: ARG53805  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone DR-4-02 recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 amino acids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumour-derived cell lines.
  • Conjugation: PE
  • anti-CD262 / TRAIL R2 antibody [DR5-01-1] (FITC)
  • Cat. No: ARG53806  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone DR5-01-1 recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2 is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L).
  • Conjugation: FITC
  • anti-CD262 / TRAIL R2 antibody [DR5-01-1] (PE)
  • Cat. No: ARG53807  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone DR5-01-1 recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2 is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L).
  • Conjugation: PE